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including age, gender, body mass index. diabetes, hypertension. angina, previous myo- 
cardial infarction, previous CABG, previous PTCA, and valvular disease. Correlation by 
univariate and multivariate analysis was determined for each of these characteristics with 
PWV. Results: Arterial stiffness by PWV measurements correlated strongly and inde- 
pendently with age and hypertension (pcO.0001 and p<O.O250, respectively). Coronary 
artery disease as defined by angicgraphy as present or absent, as obstructive or non- 
obstructive, and as three vessel or less than three vessel disease, did demonstrate a sig- 
nificant correlation with PWV measurements in univariate analysis (p=O.O095). However, 
in multivariate analysis with correction for age and blood pressure, PWV was not a signif- 
icant predictor of the presence and severity of coronary atherosclerosis (p=O.9968). The 
presence of diabetes and of elevated homocystelne levels did also show a statistically 
significant and independent correlation with PWV (p=O.O204 and p=O.O061, respec- 
tively). Conclusion: Arterial stiffness by PWV measurements correlates well with age, 
hypertension, diabetes and homocysteine levels, but does not independently predict the 
presence or severity of coronary artery disease. 
1105-119 A Comparison of Noninvasive ad Invasive Aortic Pulse 
Wave Velocity 
Sundip J. Patel. Sandnne C. Millasseau, Divaka Perera, Emma Tomsett, Phil J. 
Chowienczyk, Michael S. Marber, Simon R. Redwood, St. Thomas’ Hospital, London, 
United Kingdom 
Background: Aortic stiffness, an independent risk factor for cardiovascular disease, can 
be assessed noninvasively by measuring aortic pulse wave velocity (PWV). The tech- 
nique is easy and reproducible, and this is reflected in its widespread use in clinical stud- 
ies. However data are lacking on its comparison with invasively derived PWV Our aim is 
to compare noninvasive aortic PWV (NIX-PWV) with invasive aortic PWV (Ix-PWV). 
Methods: 15 patients undergoing elective coronary angioplasty underwent NIX-PWV 
assessment that morning with the Sphygmacor Pulse Wave AnalysisTM system. All vaso- 
active drugs had been withheld. Noninvasive transit distance (NIX-D), the estimated dis- 
tance traveled by the pressure wave in the aorta, was measured over the body surface 
from the sternal notch to the femoral pulse. Noninvasive transit time (NIX-T) was obtained 
using electrocardiogram (ECG) gated pressure traces recorded from sequential carotid- 
femoral artery tonometry. Prior to intervention, an angioplasty guide wire with a pressure 
sensor tip (RADI PressureWireTM) was positioned in the aortic root and then in the femo- 
ral artery, to obtain ECG gated pressure traces for calculation of the invasive transit time 
(Ix-T). The aortic root-femoral pullback distance (Ix-D) was marked on the wire. Noninva- 
sive and invasive measurements were repeated 3 times. Noninvasive blood pressure 
was recorded at the time of all measurements. PWV was calculated as: DIT m/s. 
Results: NIX-PWV correlated with Ix-PWV after correcting for mean arterial pressure (R= 
0.73, p<O.Oi). However, there was a mean difference between them of 1.3 m/s (14% of 
absolute mean) with a considerable variation in this difference, the standard deviation 
(SD) of the diflerence being 1.8 m/s (20%). There was also a difference between NIX-D 
and Ix-D, the mean difference being 70 mm (12% of absolute mean) and the SD of the 
difference, 39 mm (7%). 
Conclusion: Noninvasive aortic PWV can be used as an index of aortic stiffness. How- 
ever it varies considerably with invasive PWV. This may partly be due to errors in esti- 
mating noninvasIve transit distance. Thus, refining the technique may further increase 
the power of this tool to predict adverse cardiovascular outcome. 
1105-152 Brachial Artery Compliance in Hypertension: Effect of 
Losartan and Atenolol After One-Year of Treatment--A 
LIFE Substudy 
Christian Tuxen, Niels Wiinberg, Per Hlldebrandt, Jesper Mehlsen. Frederiksberg 
University Hospital, Copenhagen, Denmark 
Introduction: Central arterial compliance is an independent risk factor for mortality 
whereas matters concerning peripheral arterial compliance and effect of different treat- 
ments are unsettled. 
Methods: Fifty-six patients (24 females) from the LIFE study aged 69 years (55-80) with 
ECG-determined LVH were examined after 14 days on placebo treatment and again 
after 1 year of treatment with either losartan or atenolol in equipotent dosages. Brachial 
artenal compliance was measured using a volume-oscillometric method (Artcomp, Cri- 
tikoti). 
Results: BP was 163+21/89+15 mmHg at baselme and 154*18/81+12 mmHg after 1 
year and was similar in the treatment arms (ns). Isobaric compliance decreased after 1 
year (~~0.05) but was still elevated compared to matched controls (p=O.O02). Compli- 
ance at MAP was unchanged (ns). No difference was seen according to treatment after 
adlusting for gender, age and body surface area (IX). 
Conclusions: Brachlal artery compliance is maintained normal, only at a higher BP in 
hypertension accompanied by LVH. Isobaric brachial compliance decreases towards 
normal after 1 year of treatment, apparently irrespective of treatment with losartan or 
atenolol. 
1105-l 53 Lack of Association Between Chlamydia Pneumoniae 
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Thomas F. Smith, David 0. Wiebers, A. Jam11 Tajik, Mayo Clinic and Mayo Foundation, 
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Background: Atherosclerosis-related mechanisms may play a role in aortic dilatation 
and aneurysm formation. We examined whether infection with Chlamydia pneumoniae 
(Cpn), a pathogen presumably involved in atherogenesis, IS associated with thoracic aor- 
tic dilatation in a sample of the general population. Methods: Thoracic aortic dimensions 
(diameters at the sinuses of Valsalva [SV], ascending aorta [AA], aoRic arch, and 
descending aorta [DA]) were measured by transesophageal echocardlography in 373 
subjects (median age 66 yr, range 51.101; 52% men) participating I” a population-based 
study (SPARC: Stroke Prevention -Assessment of Risk in a Community), who were free 
of significant aortic valve disease. The association between Cpn IgG seropositivity and 
aortic dimensions was examined in 372 subjects (a single subject with positive IgM anti- 
bodies, indicating acute Cpn infection, was excluded from analysis). Results: Age, male 
gender, and body surface area (BSA) were significant determinants of aortic diameters, 
jointly accounting for 41% 31%, 38% and 47% of the variability in aoflic diameter at the 
SV (mean diameter f SD: 33.7q3.8 mm), AA (33.323.8 mm), aortic arch (27.4i2.8 mm), 
and DA (25.99.0 mm), respect&y. Cpn antibodies (titers ,1:16) were present in 274 
subjects (74%): low titers (1:16-1:32) in 57 (15%), intermediate titers (1:64-1:128) in 137 
(37%), and high titers (21:256) in 80 subjects (22%). Cpn titers were not associated with 
the diameter of the SV (f=O.79). AA (EO.96) aortic arch (EO.58), and DA (EO.51). 
adjusting for age, sex. BSA. and smoking status (Pvalues are for the joint inclusion of all 
Cpn titer levels in the respective models). Conclusions: Cpn seropositwity is not associ- 
ated with thoracic aortic dilatation in the general population. These findings do not sup- 
port a role for Cpn infection in the pathogenesis of thoracic aortic dilatation and, 
probably, in aortic aneurysm formation. 
1105-154 Sildenafil Improves Left Ventricular Systolic Function in 
Patients With Conaestive Heart Failure: The Role of 
Wave Reflections - 
Kozo Hirata. Audrey Adji, Charalambos Vlachopoulos, Michael F. O’Rourke. St. 
Vincent’s Clinic, University of New South Wales, Sydney, Australia 
Background: Sildenafil (S) is an effective drug for erectile dysfunchon affecting the nitnc 
oxide-cGMP pathway. Wave reflection is an Important index of arterial stiffening and car- 
diac afterload and has been inversely associated with exercise capacity. 
Methods: To investigate the effect of S on cardiac function and wave reflection in con- 
gestive hearl failure (CHF) we studied 20 pts (age 48-88 yrs) in NYHA class II or (II 
(EF<35%), in a randomized, double-blind, placebo-controlled, cross-over design (50 mg 
of S and placebo). Wave reflection was studied by measuring augmentation index (Alx) 
using a validated system (SphygmoCoa) that employs high-fidelity artenal tonometry 
and pulse wave analysis. Cardiac output was measured by echocardiography. 
Results: S was well tolerated with no side effects in any patlent S led to a increase in 
cardiac index (by 0.38 Ilminim2, PcO.0001. graph). This was associated with. and attrib- 
utable to, a decrease in left ventricular load (aortic and left ventricular systolic pressure 
fell by 13.9 mmHg, PcO.0001). Alx was decreased by 3.5% (P<O.OOOl; graph) indicating 
reduced wave reflection from peripheral sites. Total systemic resistance fell by 478.5 
dynes-secwm~5 (p<O.OOOl; graph). 
Conclusions: S leads to an Improvement in cardiac function in CHF patients which is 
associated with a favorable effect on central and penpheral a&anal properties. This has 
important implications for the therapeutic profile of the drug in patients with compromised 
cardiac performance. 
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